Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Fluorine-18 2-deoxy-2-fluoro-D-glucose (FDG) accumulation in tumours has been well investigated, but much less is known regarding FDG accumulation in inflammatory lesions. In this study, we determined the effects of hypo- and hyperglycaemia on FDG uptake in inflammatory lesions of infectious and non-infectious origin and compared them with those in malignant tumours in rats, to provide a biological basis for differentiating malignant lesions from benign lesions by means of FDG-PET. Rats were inoculated with a suspension of allogenic hepatoma cells (KDH-8) or Staphylococcus aureus, or with turpentine oil into the left calf muscle. Two weeks after KDH-8 inoculation and 1 week after S. aureus and turpentine oil inoculations, the rats were divided into three subgroups: insulin-loaded (2 U/kg body weight, i.p.), glucose-loaded (1.2 g/kg body weight, p.o.) and control groups. Radioactivity in tissues was determined 1 h after i.v. injection of FDG. Intraperitoneal injection of insulin and oral administration of glucose induced hypoglycaemia and hyperglycaemia, respectively. In the control animals, tumours showed a level of FDG uptake which was 2.2 and 3.0 times higher than the levels in the inflammatory lesions induced by S. aureus and turpentine oil, respectively (P<0.0001). There was no significant difference in the level of FDG uptake between the two inflammatory lesions of infectious and non-infectious origin. Insulin loading significantly decreased the level of FDG uptake in tumours and in both types of inflammatory lesion to approximately one-half of the control values (P=0.001 in the tumour group and P<0.0001 in the two inflammatory lesion groups). In the glucose-loaded group, the level of FDG uptake in both types of inflammatory lesion decreased significantly to 50%-61% of the control value (P=0.0002 in the S. aureus group and P<0.0001 in the turpetine group), while the tumour uptake did not decrease significantly (86% of the control value) (P=NS). It is concluded that FDG uptake in both types of inflammatory lesion was significantly impaired in rats with hyperglycaemia induced by glucose loading, while tumour uptake of FDG was not significantly affected. These results indicate that glucose loading has greater effects on FDG uptake in inflammatory lesions than in tumours, providing a biological basis for differentiation of malignant lesions from benign lesions by FDG-PET in a clinical setting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, unnecessary interventions aimed at lowering the BGL are time-and resources-consuming, including insulin injection, which may also increase background FDG uptake and therefore decrease PET scan sensitivity [42].”
In the citing paper
“or the possibility of insulin-induced FDG shunting from tumors to muscles, thus decreasing tumor to background FDG uptake ratio [42,112,113].”
In the citing paper
“This approach may lead to increased costs, inconvenience for patients, unnecessary postponing of PET scan, and delays in diagnosis of potential malignancies”
Citations
Cites
Flier, J. S., Mueckler, M. M., Usher, P., & Lodish, H. F. (1987) · Science · doi:10.1126/science.3103217 · Cited by 786 · cited 1×
“Fluorine-18 2-deoxy-2-fluoro-D-glucose (FDG) has been widely used to visualise and stage malignant tumours and to differentiate malignant lesions from benign lesions by positron emission tomography (PET) [1, 2, 3, 4, 5, 6, 7, 8, 9]. These applications are based on accumulation of FDG due to increased glucose utilisati…”
BackgroundWahl, R. L., Zasadny, K., Helvie, M., Hutchins, G. D., Weber, B., & Cody, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2101 · Cited by 605
Som, P., Atkins, H. L., Bandoypadhyay, D., Fowler, J. S., MacGregor, R. R., Matsui, K., Oster, Z. H., Sacker, D. F., Shiue, C. Y., Turner, H., et al. (1980) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198012000-00045 · Cited by 504 · cited 1×
“Fluorine-18 2-deoxy-2-fluoro-D-glucose (FDG) has been widely used to visualise and stage malignant tumours and to differentiate malignant lesions from benign lesions by positron emission tomography (PET) [ 1 , 2, 3, 4, 5, 6, 7, 8, 9]. These applications are based on accumulation of FDG due to increased glucose utilisa…”
Background(1995) · PubMed · Cited by 474
Garvey, W. T., Maianu, L., Zhu, J. H., Brechtel-Hook, G., Wallace, P., & Baron, A. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1557 · Cited by 459 · cited 1×
“It is well known that glucose uptake in peripheral tissues is impaired in infectious diseases owing to peripheral insulin resistance mediated by Glut-4 transporter [31, 32 ].”
BackgroundWahl, R. L., Cody, R. L., Hutchins, G. D., & Mudgett, E. E. (1991) · Radiology · doi:10.1148/radiology.179.3.2027989 · Cited by 431
Wahl, R. L., Quint, L. E., Greenough, R. L., Meyer, C. R., White, R. I., & Orringer, M. B. (1994) · Radiology · doi:10.1148/radiology.191.2.8153308 · Cited by 430
(1993) · PubMed · Cited by 398
Steinert, H. C., Hauser, M., Allemann, F., Engel, H., Berthold, T., von Schulthess, G. K., & Weder, W. (1997) · Radiology · doi:10.1148/radiology.202.2.9015071 · Cited by 376
Differential diagnosis of lung tumor with positron emission tomography: A prospective study
(1991) · Lung Cancer · doi:10.1016/0169-5002(91)90324-y · Cited by 321
Hustinx, R., Smith, R. J., Benard, F., Rosenthal, D. I., Machtay, M., Farber, L. A., & Alavi, A. (1999) · European Journal of Nuclear Medicine · doi:10.1007/s002590050593 · Cited by 290
Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
Lewis, P. J., & Salama, A. (1994) · PubMed · Cited by 287
Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver
Vitola, J. V., Delbeke, D., Sandler, M. P., Campbell, M. G., Powers, T. A., Wright, J. K., Chapman, W. C., & Pinson, C. W. (1996) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80067-1 · Cited by 228 · cited 1×
“Fluorine-18 2-deoxy-2-fluoro-D-glucose (FDG) has been widely used to visualise and stage malignant tumours and to differentiate malignant lesions from benign lesions by positron emission tomography (PET) [1, 2, 3, 4 , 5, 6, 7, 8, 9]. These applications are based on accumulation of FDG due to increased glucose utilisat…”
BackgroundWahl, R. L., Henry, C. A., & Ethier, S. P. (1992) · Radiology · doi:10.1148/radiology.183.3.1584912 · Cited by 206
(1993) · PubMed · Cited by 197
FDG-PET in infectious lesions: The detection and assessment of lesion activity
Ichiya, Y., Kuwabara, Y., Sasaki, M., Yoshida, T., Akashi, Y., Murayama, S., Nakamura, K., Fukumura, T., & Masuda, K. (1996) · Annals of Nuclear Medicine · doi:10.1007/bf03165391 · Cited by 192 · cited 2×
“Recent investigations, however, have demonstrated that FDG accumulates not only in malignant tumours but also in inflammatory lesions in experimental animals and in humans [11, 12, 13, 14 , 15, 16, 17, 18, 19].”
BackgroundHigh [18F]-Fluorodeoxyglucose Uptake in Abdominal Abscesses: A PET Study
Tahara, T., Ichiya, Y., Kuwabara, Y., Otsuka, M., Miyake, Y., Gunasekera, R., & Masuda, K. (1989) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198909000-00014 · Cited by 173 · cited 2×
“To the best of our knowledge, the effect of the serum glucose level on FDG uptake in inflammatory lesions has not been investigated, although high accumulation of FDG in inflammatory lesions has been reported in clinical [ 11 , 12, 13, 14, 15, 16, 17] and experimental studies [18, 19].”
BackgroundInokuma, T., Tamaki, N., Torizuka, T., Magata, Y., Fujii, M., Yonekura, Y., Kajiyama, T., Ohshio, G., Imamura, M., & Konishi, J. (1995) · Radiology · doi:10.1148/radiology.195.2.7724751 · Cited by 158
Self-citationToorongian, S. A., Mulholland, G. K., Jewett, D. M., Bachelor, M. A., & Kilbourn, M. R. (1990) · International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology · doi:10.1016/0883-2897(90)90052-3 · Cited by 148 · cited 1×
“Each rat was anaesthetised with pentobarbital (50 mg/kg, i.p.) and was injected in the tail vein with 5‐6 MBq of FDG synthesised as previously described [ 27 ].”
MethodValue of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
Torizuka, T., Tamaki, N., Inokuma, T., Magata, Y., Yonekura, Y., Tanaka, A., Yamaoka, Y., Yamamoto, K., & Konishi, J. (1994) · PubMed · Cited by 128
Self-citationSugawara, Y., Gutowski, T. D., Fisher, S. J., Brown, R. S., & Wahl, R. L. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050395 · Cited by 124
FDG-PET in the Selection of Brain Lesions for Biopsy
Hanson, M. W., Glantz, M., Hoffman, J. M., Friedman, A. H., Burger, P. C., Schold, S. C., & Coleman, R. E. (1991) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199109000-00013 · Cited by 97 · cited 2×
“Recent investigations, however, have demonstrated that FDG accumulates not only in malignant tumours but also in inflammatory lesions in experimental animals and in humans [11, 12, 13, 14, 15 , 16, 17, 18, 19].”
BackgroundEffects of hyperglycemia on FDG uptake in human brain and glioma.
Ishizu, K., Nishizawa, S., Yonekura, Y., Sadato, N., Magata, Y., Tamaki, N., Tsuchida, T., Okazawa, H., Miyatake, S., & Ishikawa, M. (1994) · PubMed · Cited by 91
Self-citationRinglike uptake of [18F]FDG in brain abscess: a PET study.
Sasaki, M., Ichiya, Y., Kuwabara, Y., Otsuka, M., Tahara, T., Fukumura, T., Gunasekera, R. D., & Masuda, K. (1990) · PubMed · Cited by 86
Mechanisms of hepatic and peripheral insulin resistance during acute infections in humans.
Virkamäki, A., Puhakainen, I., Koivisto, V. A., Vuorinen-Markkola, H., & Yki-Järvinen, H. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1740504 · Cited by 65 · cited 1×
“It is well known that glucose uptake in peripheral tissues is impaired in infectious diseases owing to peripheral insulin resistance mediated by Glut-4 transporter [ 31 , 32].”
BackgroundIn vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma
Minn, H., Lindholm, P., Nuutila, P., Ruotsalainen, U., Teräs, M., Juhani Knuuti, M., & Bergman, J. (1994) · Cancer · doi:10.1002/1097-0142(19940301)73:5<1490::aid-cncr2820730528>3.0.co;2-h · Cited by 45 · cited 1×
“It has been reported in experimental and clinical PET studies that the level of FDG uptake in tumours is significantly decreased both in individuals with hypoglycaemia [ 20 , 21, 22] and in those with hyperglycaemia [23, 24, 25].”
BackgroundValidity of PET studies in brain tumors.
Herholz, K., Wienhard, K., & Wd, H. (1990) · PubMed · Cited by 37
Discordance Between F-18 Fluorodeoxyglucose Uptake and Contrast Enhancement in a Brain Abscess
Meyer, M., Frey, K. A., & Schwaiger, M. (1993) · Clinical Nuclear Medicine · doi:10.1097/00003072-199308000-00013 · Cited by 36 · cited 2×
“To the best of our knowledge, the effect of the serum glucose level on FDG uptake in inflammatory lesions has not been investigated, although high accumulation of FDG in inflammatory lesions has been reported in clinical [11, 12, 13, 14, 15, 16 , 17] and experimental studies [18, 19].”
BackgroundTorizuka, T., Fisher, S. J., & Wahl, R. L. (1997) · Radiology · doi:10.1148/radiology.203.1.9122387 · Cited by 32
Kuramitsu, Y., Nishibe, M., Ohiro, Y., Matsushita, K., Yuan, L., Obara, M., Kobayashi, M., & Hosokawa, M. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199706000-00013 · Cited by 27
Self-citationEffect of insulin on uptake of FDG by experimental mammary carcinoma in diabetic rats.
Torizuka, T., Fisher, S. J., Brown, R. S., & Wahl, R. L. (1998) · Radiology · doi:10.1148/radiology.208.2.9680582 · Cited by 24
Targeting of the insulin-regulatable glucose transporter (GLUT-4)
James, D. E. (1994) · Biochemical Society Transactions · doi:10.1042/bst0220668 · Cited by 17
Juhlin, C., Rastad, J., Åkerström, G., Papanicolaou, V., Öberg, K., Arnberg, H., Klareskog, L., & Lörelius, L. (1994) · Cancer · doi:10.1002/1097-0142(19940301)73:5<1346::aid-cncr2820730507>3.0.co;2-c · Cited by 6
Cited by
Zhuang, H., & Alavi, A. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.29278 · Cited by 524
18F-FDG PET and PET/CT in fever of unknown origin.
Meller, J., Sahlmann, C., & Scheel, A. (2007) · PubMed · Cited by 323
on behalf of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM), Bucerius, J., Hyafil, F., Verberne, H. J., Slart, R. H. J. A., Lindner, O., Sciagra, R., Agostini, D., Übleis, C., Gimelli, A., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3259-3 · Cited by 257
“tious lesions [27, 28].”
Positron emission tomography imaging in nonmalignant thoracic disorders
Alavi, A., Gupta, N., Alberini, J.-L., Hickeson, M., Adam, L.-E., Bhargava, P., & Zhuang, H. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.127291 · Cited by 218
De Winter, F., Vogelaers, D., Gemmel, F., & Dierckx, R. (2002) · European Journal of Clinical Microbiology and Infectious Diseases · doi:10.1007/s10096-002-0708-2 · Cited by 195
Metadata
- Authors
- Zhao, S., Kuge, Y., Tsukamoto, E., Mochizuki, T., Kato, T., Hikosaka, K., Hosokawa, M., Kohanawa, M., & Tamaki, N.
- Affiliations
- Hokkaido University (JP)
- Nikko Memorial Hospital (JP)
- Corresponding author
- Kuge, Yuji
- Venue
- European Journal of Nuclear Medicine
- Published
- 2001-06
- Volume
- 28
- Issue
- 6
- Pages
- 730-735
- ISSN
- 1619-7070 (ISSN-L)
- 0340-6997
- 1619-7089
- OpenAlex
- W1561754985
- Cited by
- 68
- References
- 32
- Citations by year
- 2026: 5 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 2 · 2015: 1 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- insulin, glucose load, hypoglycemia, hyperglycemia, cancer, inflammatory lesions, FDG-PET, Staphylococcus aureus infection, turpentine-induced inflammation, rats, tumor glucose metabolism
- MeSH terms
- Animals, Blood Glucose, Glucose, Hypoglycemic Agents, Inflammation, Insulin, Liver Neoplasms, Experimental, Male, Neoplasm Transplantation, Radionuclide Imaging, Staphylococcal Infections, Tissue Distribution, Rats, Wistar, Radiopharmaceuticals, Fluorodeoxyglucose F18, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.